314 related articles for article (PubMed ID: 25609247)
1. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.
van Gijn W; van Stiphout RGPM; van de Velde CJH; Valentini V; Lammering G; Gambacorta MA; Påhlman L; Bujko K; Lambin P
Ann Oncol; 2015 May; 26(5):928-935. PubMed ID: 25609247
[TBL] [Abstract][Full Text] [Related]
2. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.
Valentini V; van Stiphout RG; Lammering G; Gambacorta MA; Barba MC; Bebenek M; Bonnetain F; Bosset JF; Bujko K; Cionini L; Gerard JP; Rödel C; Sainato A; Sauer R; Minsky BD; Collette L; Lambin P
J Clin Oncol; 2011 Aug; 29(23):3163-72. PubMed ID: 21747092
[TBL] [Abstract][Full Text] [Related]
3. Validation of a rectal cancer outcome prediction model with a cohort of Chinese patients.
Shen L; van Soest J; Wang J; Yu J; Hu W; Gong YU; Valentini V; Xiao Y; Dekker A; Zhang Z
Oncotarget; 2015 Nov; 6(35):38327-35. PubMed ID: 26413811
[TBL] [Abstract][Full Text] [Related]
4. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
5. Abdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection margin.
Wang L; Gu GL; Li ZW; Peng YF; Gu J
World J Gastroenterol; 2014 Jul; 20(27):9138-45. PubMed ID: 25083087
[TBL] [Abstract][Full Text] [Related]
6. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
7. Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancers.
Peng J; Ding Y; Tu S; Shi D; Sun L; Li X; Wu H; Cai S
PLoS One; 2014; 9(8):e106344. PubMed ID: 25171093
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Janjan NA; Delclos ME; Krishnan S; Levy LB; Ellis LM; Crane CH
Am J Clin Oncol; 2006 Jun; 29(3):219-24. PubMed ID: 16755173
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer.
Tsujinaka S; Kawamura YJ; Konishi F; Aihara H; Maeda T; Mizokami K
Int J Colorectal Dis; 2008 Jan; 23(1):67-76. PubMed ID: 17704925
[TBL] [Abstract][Full Text] [Related]
10. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.
van Gijn W; Marijnen CA; Nagtegaal ID; Kranenbarg EM; Putter H; Wiggers T; Rutten HJ; Påhlman L; Glimelius B; van de Velde CJ;
Lancet Oncol; 2011 Jun; 12(6):575-82. PubMed ID: 21596621
[TBL] [Abstract][Full Text] [Related]
11. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study.
Räsänen M; Renkonen-Sinisalo L; Mustonen H; Lepistö A
World J Surg Oncol; 2019 Aug; 17(1):139. PubMed ID: 31395058
[TBL] [Abstract][Full Text] [Related]
12. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
Gollins S; Sun Myint A; Haylock B; Wise M; Saunders M; Neupane R; Essapen S; Samuel L; Dougal M; Lloyd A; Morris J; Topham C; Susnerwala S
J Clin Oncol; 2011 Mar; 29(8):1042-9. PubMed ID: 21263095
[TBL] [Abstract][Full Text] [Related]
13. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
15. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
[TBL] [Abstract][Full Text] [Related]
16. Local recurrence of rectal cancer after total mesorectal excision without preoperative radiotherapy.
van Lingen CP; Zeebregts CJ; Gerritsen JJ; Mulder HJ; Mastboom WJ; Klaase JM
Int J Gastrointest Cancer; 2003; 34(2-3):129-34. PubMed ID: 15361646
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.
Park IJ; You YN; Agarwal A; Skibber JM; Rodriguez-Bigas MA; Eng C; Feig BW; Das P; Krishnan S; Crane CH; Hu CY; Chang GJ
J Clin Oncol; 2012 May; 30(15):1770-6. PubMed ID: 22493423
[TBL] [Abstract][Full Text] [Related]
18. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
[TBL] [Abstract][Full Text] [Related]
19. Modified neoadjuvant short-course radiation therapy in uT3 rectal carcinoma: low local recurrence rate with unchanged overall survival and frequent morbidity.
Kube R; Ptok H; Jacob D; Fahlke J; Mroczkowski P; Lippert H; Ziegenhardt G; Schmidt U; Gastinger I
Int J Colorectal Dis; 2010 Jan; 25(1):109-17. PubMed ID: 19876634
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up.
Pach R; Kulig J; Richter P; Gach T; Szura M; Kowalska T
Langenbecks Arch Surg; 2012 Jun; 397(5):801-7. PubMed ID: 22170083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
